MAPT and Alzheimer disease: elegans model, suppression of this gene either by RNAi or inhibitor resulted in increased whole-body glucose levels and Tau phosphorylation, consistent with the observation in AD patients [245], suggesting that the disturbance in energy metabolism can significantly induce the neurotoxicity of pathological Tau [246].